Cannabis use in patients with early psychosis is associated with alterations in putamen and thalamic shape.

Human Brain Mapping
Musa SamiS Bhattacharyya

Abstract

Around half of patients with early psychosis have a history of cannabis use. We aimed to determine if there are neurobiological differences in these the subgroups of persons with psychosis with and without a history of cannabis use. We expected to see regional deflations in hippocampus as a neurotoxic effect and regional inflations in striatal regions implicated in addictive processes. Volumetric, T1w MRIs were acquired from people with a diagnosis psychosis with (PwP + C = 28) or without (PwP - C = 26) a history of cannabis use; and Controls with (C + C = 16) or without (C - C = 22) cannabis use. We undertook vertex-based shape analysis of the brainstem, amygdala, hippocampus, globus pallidus, nucleus accumbens, caudate, putamen, thalamus using FSL FIRST. Clusters were defined through Threshold Free Cluster Enhancement and Family Wise Error was set at p < .05. We adjusted analyses for age, sex, tobacco and alcohol use. The putamen (bilaterally) and the right thalamus showed regional enlargement in PwP + C versus PwP - C. There were no areas of regional deflation. There were no significant differences between C + C and C - C. Cannabis use in participants with psychosis is associated with morphological alterations in subcortical...Continue Reading

References

Sep 1, 1991·British Journal of Addiction·T F HeathertonK O Fagerström
Jan 1, 1987·Schizophrenia Bulletin·S R KayL A Opler
Aug 23, 2002·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·María-Trinidad HerreroJuana Mari Navarro
Jan 23, 2003·Psychological Medicine·D M FergussonN R Swain-Campbell
Feb 27, 2004·Schizophrenia Research·W CahnR S Kahn
Dec 21, 2004·Drug and Alcohol Dependence·John A MatochikKaren I Bolla
Apr 30, 2005·Biological Psychiatry·Linda ChangThomas Ernst
Oct 28, 2005·Nature Neuroscience·Barry J Everitt, Trevor W Robbins
Mar 3, 2007·The British Journal of Psychiatry : the Journal of Mental Science·Philip R SzeszkoRobert M Bilder
Feb 19, 2008·The American Journal of Psychiatry·Monica RaisRené Kahn
Sep 23, 2008·Schizophrenia Research·Miguel Ruiz-VeguillaJorge Cervilla
Aug 28, 2009·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·George F Koob, Nora D Volkow
Feb 16, 2010·Neuron·Michael S Fanselow, Hong-Wei Dong
Mar 13, 2010·Schizophrenia Bulletin·Killian A WelchEve C Johnstone
Apr 3, 2010·The American Journal of Psychiatry·David M GardnerRoss J Baldessarini
Aug 28, 2010·Journal of Psychiatric Research·Matthew J SmithJohn G Csernansky
Sep 25, 2010·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Monica RaisRené S Kahn
Oct 19, 2010·Biological Psychiatry·Petra HabetsUNKNOWN Genetic Risk and Outcome of Psychosis (G.R.O.U.P)
Feb 9, 2011·Archives of General Psychiatry·Matthew LargeOlav Nielssen
Mar 1, 2011·NeuroImage·Brian PatenaudeMark Jenkinson
May 12, 2011·The International Journal of Neuropsychopharmacology·Martin CohenUlrich Schall
Sep 3, 2011·Psychiatric Services : a Journal of the American Psychiatric Association·Jennifer P WisdomRobert E Drake
Sep 10, 2011·The British Journal of Psychiatry : the Journal of Mental Science·Killian A WelchEve C Johnstone
Jan 24, 2012·Journal of the American Academy of Child and Adolescent Psychiatry·Sanjiv KumraKelvin Lim
Feb 4, 2012·Science·Karen D ErscheEdward T Bullmore
Dec 4, 2012·Schizophrenia Research·Nadia SolowijMurat Yücel
Feb 27, 2013·Neuroscience and Biobehavioral Reviews·Barry J Everitt, Trevor W Robbins
May 16, 2013·Schizophrenia Research·Paulo Jannuzzi CunhaMaristela S Schaufelberger
Sep 24, 2013·Psychiatry Research·Charlotte RappAnita Riecher-Rössler
Oct 3, 2013·European Archives of Psychiatry and Clinical Neuroscience·Berend MalchowThomas Wobrock
Oct 17, 2013·Frontiers in Systems Neuroscience·Laura A BradfieldBernard W Balleine
Feb 18, 2014·NeuroImage·Anderson M WinklerThomas E Nichols
Apr 18, 2014·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Jodi M GilmanHans C Breiter
Jul 24, 2014·Psychological Medicine·E Manrique-GarciaP Allebeck
Dec 17, 2014·Journal of Psychiatry & Neuroscience : JPN·Laura KoendersLieuwe de Haan

❮ Previous
Next ❯

Software Mentioned

FreeSurfer
FSL Randomise
FIRST
FSL FIRST

Related Concepts

Related Feeds

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.

Amygdala: Sensory Processes

Amygdalae, nuclei clusters located in the temporal lobe of the brain, play a role in memory, emotional responses, and decision-making. Here is the latest research on sensory processes in the amygdala.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Related Papers

Lancet
John MacLeodMatthias Egger
The British Journal of Psychiatry : the Journal of Mental Science
J Lindesay
British Journal of Addiction
A H Ghodse
The British Journal of Psychiatry : the Journal of Mental Science
Jonathan Ornstein, James Stone
The Lancet. Psychiatry
Timothy J Crow
© 2021 Meta ULC. All rights reserved